Search results, if found, will automatically update as terms are selected. If no results are displayed, please revise your search terms.
Filter By:
-
Alex Y.C. Huang, MD, PhD
Professor, Department of Pediatrics, School of MedicineProfessor, Department of Pathology, School of MedicineCo-Leader, Immune Oncology Program, Case Comprehensive Cancer CenterDirector, Medical Scientist Training Program, School of MedicineEmail: alex.y.huang@case.edu
Phone: 216.368.1271
I research the regulation between immune activation and tolerance in the pathogenesis of cancer, and intravital 2-photon laser scanning microscopy to study various aspects of in vivo immunity and pathogenesis.
-
Sudha K. Iyengar, PhD
Professor and Vice Chair for Research, Department of Population and Quantitative Health Sciences, School of MedicineFrederick C. Robbins, M.D. Professor in Child and Adolescent Health, Department of Population and Quantitative Health Sciences, School of MedicineProfessor, Department of Genetics and Genome Sciences, School of MedicineProfessor, Department of Ophthalmology and Visual Sciences, School of MedicineFaculty, Cleveland Institute for Computational Biology, School of MedicineMember, Cancer Genomics and Epigenomics Program, Case Comprehensive Cancer CenterEmail: sudha.iyengar@case.edu
Phone: 216.368.4388
I research molecular and statistical genetic dissection of multifactorial diseases; common chronic diseases of the eye and the kidney; speech sound disorder.
-
Mark Jackson, PhD
Vice Dean, Graduate Education, School of MedicineProfessor, Department of Pathology, School of MedicineDirector, Cancer Biology Training ProgramMember, Molecular Oncology Program, Case Comprehensive Cancer CenterEmail: mark.w.jackson@case.edu
Phone: 216.368.1276
My area of investigation includes tumor microenvironment, tumor immunology, mestastasis, and cellular transformation.
-
Beata Jastrzebska, PhD
Associate Professor, Department of Pharmacology, School of MedicineMember, Cleveland Center for Membrane & Structural BiologyEmail: bxj27@case.edu
Phone: 216.368.5683
My areas of research include signaling complexes of rhodopsin, rhodopsin oligomeric organization in signal transduction, Molecular bases of light-induced retinal degeneration, and mouse models of retinal degenerative diseases.
-
Fulai Jin, PhD
Professor, Department of Genetics and Genome Sciences, School of MedicineAssociate Professor, Department of Population and Quantitative Health Sciences, School of MedicineAssociate Professor, Department of Computer and Data Sciences, Case School of EngineeringCo-Leader, Cancer Genomics and Epigenomics Program, Case Comprehensive Cancer CenterEmail: fulai.jin@case.edu
Phone: 216.368.1811
I study molecular mechanisms and gene regulatory functions of 3D genome architecture, computational and system biology tools for integrative analysis of genomic data, and single cell transcriptome/epigenome technologies in health and disease.
-
Jae Jung, PhD
Director, Global Center for Pathogen & Human Health Research, Cleveland Clinic Lerner College of Medicine of Case Western Reserve UniversityEmail: jungj@ccf.org
Virus-induced cancer, Emerging viruses, Therapeutics and Vaccine Development, Inflammation and Immunity
-
David Kang, PhD
Professor, Department of Pathology, School of MedicineHoward T. Karsner Professor in PathologyEmail: dek94@case.edu
Phone: 216.368.0488
Dr. Kang’s research focuses on the molecular pathways underlying aberrant proteinopathy and neurotoxicity in Alzheimer’s disease (AD) and Related Dementias (ADRDs), including Frontotemporal dementia (FTD)-Amyotrophic lateral sclerosis (ALS) spectrum disorders and Lewy body disorders (LBD).
-
Hung-Ying Kao, PhD
Professor, Department of Biochemistry, School of MedicineDirector of Graduate Programs, Department of Biochemistry, School of MedicineMember, Molecular Oncology Program, Case Comprehensive Cancer CenterEmail: hung.kao@case.edu
Phone: 216.368.1150
Our lab is interested in the underlying mechanism and identifying anticancer targets of breast cancer.
-
Mihriban Karaayvaz, PhD
Assistant Professor, Cleveland Clinic Lerner College of Medicine, Lerner Research Institute, Cleveland Clinic, School of MedicineMember, Molecular Oncology Program, Case Comprehensive Cancer CenterEmail: karaaym@ccf.org
The Karaayvaz Lab’s main research focus is to understand the early events in breast cancer development in high-risk patients. We employ state-of-the-art single cell and imaging approaches to dissect molecular heterogeneity in pre-malignant and malignant lesions of the breast. Our goal is to leverage the knowledge gained from these studies and develop innovative strategies for breast cancer chemoprevention and treatment.
-
Gunnur Karakurt, PhD
Associate Professor, School of MedicineEmail: gkk6@case.edu
Intimate partner violence is a complex problem that intersects issues from the biological level to larger societal issues intersecting individuals and families. We are interested in preventing and treating Intimate Partner Violence. Our lab aims to develop a decision-making model to improve treatment outcomes by identifying subgroups of the population who respond similarly to IPV treatments and identify which IPV treatments work best for each subgroup based on violence typology, population characteristics, and treatment options. We are also interested in understanding the interactions in which violent behaviors emerge and escalate, and how this is related to mental and physical health.